|Bid||16.140 x 0|
|Ask||16.200 x 0|
|Day's Range||15.980 - 16.420|
|52 Week Range||11.320 - 20.500|
|Beta (5Y Monthly)||1.00|
|PE Ratio (TTM)||18.01|
|Earnings Date||Aug 27, 2020|
|Forward Dividend & Yield||0.32 (1.99%)|
|Ex-Dividend Date||Jun 22, 2020|
|1y Target Est||25.11|
Beijing-based TravelSky Technology Ltd is advising its employees to take a candidate vaccine being developed by China National Pharmaceutical Group (Sinopharm) amid the capital's latest COVID-19 flare-up, state newspaper Global Times reported. No vaccine has yet been proven to effectively protect people from the disease caused by the novel coronavirus that has killed more than 400,000 people globally, but multiple candidates are in development. TravelSky Technology, controlled by state-owned China TravelSky Holding Company, is the country's dominant provider of information technology to the air travel and tourism industries.
TravelSky Technology (HKG:696) has had a rough three months with its share price down 25%. However, stock prices are...
Dividend paying stocks like TravelSky Technology Limited (HKG:696) tend to be popular with investors, and for good...